GEV vs JNJ · P/E 28, rev $38.07B vs P/E 17, rev $49.37B
GE Vernova LLC (GEV) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
GE Vernova LLC (GEV) is a specialty industrial machinery company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported GEV revenue for 2025-12-31 was $38.07B. Net income was $4.88B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. GEV currently screens at market cap $260.21B and trailing P/E 28.3.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
GEV currently screens at market cap $260.21B and trailing P/E 28.3. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the GEV and JNJ stock pages for the full models.
Not investment advice.